Takako Sano

发表

EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.

Y. Hasegawa, Y. Sekido, Mitsuo Sato, 2013, Cancer research.

Combined TherapywithMutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer

T. Mitsudomi, Y. Sekido, T. Nakagawa, 2012 .

Circumvented in Combination with HDAC Inhibition

Y. Sekido, Mitsuo Sato, T. Nakagawa, 2013 .

High glucose-mediated overexpression of ICAM-1 in human vaginal epithelial cells increases adhesion of Candida albicans

Takako Sano, H. Mikamo, Hiroyuki Sugiyama, 2018, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Detection of Slow-Growing Spirillum in Blood Culture During Chemotherapy for Malignant Lymphoma

Takako Sano, T. Murata, Yuji Bessho, 2015 .

Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation

T. Nakagawa, S. Yano, Kunio Matsumoto, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The novel phosphoinositide 3‐kinase–mammalian target of rapamycin inhibitor, BEZ235, circumvents erlotinib resistance of epidermal growth factor receptor mutant lung cancer cells triggered by hepatocyte growth factor

T. Nakagawa, S. Yano, Kunio Matsumoto, 2013, International journal of cancer.

Ability of the Met Kinase Inhibitor Crizotinib and New Generation EGFR Inhibitors to Overcome Resistance to EGFR Inhibitors

T. Nakagawa, S. Yano, Kunio Matsumoto, 2013, PloS one.

Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer

T. Mitsudomi, Y. Sekido, T. Nakagawa, 2012, Molecular Cancer Therapeutics.

Therapeutic Discovery Combined TherapywithMutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer

T. Mitsudomi, Y. Sekido, T. Nakagawa, 2012 .

mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF

T. Nakagawa, S. Yano, Kunio Matsumoto, 2013, PloS one.

Quantitation of HIV-1 group M proviral DNA using TaqMan MGB real-time PCR.

Y. Takebe, Takako Sano, M. Imai, 2009, Journal of virological methods.

Nationwide and long-term molecular epidemiologic studies of mumps viruses that circulated in Japan between 1986 and 2017

Kaori Watanabe, C. Hirokawa, H. Katoh, 2022, Frontiers in Microbiology.

Comparative evaluation of the Geenius HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population

T. Kawahata, N. Tachikawa, Takako Sano, 2018, PloS one.

Comparative evaluation of the Geenius™ HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population

T. Kawahata, N. Tachikawa, Takako Sano, 2018, bioRxiv.

Emergence in Japan of an HIV-1 Variant Associated with Transmission among Men Who Have Sex with Men (MSM) in China: First Indication of the International Dissemination of the Chinese MSM Lineage

P. Lemey, Y. Takebe, N. Tachikawa, 2013, Journal of Virology.

Intercontinental Dispersal of HIV-1 Subtype B Associated with Transmission among Men Who Have Sex with Men in Japan

O. Pybus, A. Leigh Brown, Y. Takebe, 2014, Journal of Virology.

[Evaluation of a new vesion of the human immunodeficiency virus antigen and antibody combination assay with improved sensitivity in HIV-1 p24 antigen detection].

N. Tachikawa, Takako Sano, M. Imai, 2013, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

T. Nakagawa, S. Yano, Kunio Matsumoto, 2013, International journal of cancer.